Insomnia. Diagnosis and management
1Sleep Research Group, Institute of Respiratory Medicine, University of Sydney. rrg@mail.med.usyd.edu.au
Background:
Insomnia is a complaint of perceived poor sleep quality resulting in impairment of daytime function. It is the commonest clinical sleep disorder with approximately 6-12% of adults complaining of chronic insomnia.
Objective:
To review current knowledge on causes and effects of insomnia and to provide a brief evidence based review of management options for the family practitioner.
Discussion:
Patients with insomnia are characterised by excessive arousal and an inability to sleep despite reported reduced sleep hours and poor sleep quality. Current management approaches are focussed on reducing this 'hyperarousal' and its behavioural manifestations by a range of behavioural treatments. Good evidence exists for the efficacy of hypnotics for short term insomnia but long term data is currently lacking. Nonbenzodiazepine hypnotics (zopiclone, zolpidem) have less adverse effects and similar efficacy to benzodiazepines.
Related Concept Videos
Management of Insomnia
Insomnia
Multiple factors contribute...
Narcolepsy
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Sleepwalking and Sleep Talking
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
CNS Depressants: Barbiturates and Benzodiazepines

